| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Original Research Communication |
1 From the Neuroendocrine Unit (GM, CH, PR, and SG), the Program in Nutritional Metabolism (GM, CH, and SG), and the Combined Program in Pediatric Gastroenterology and Nutrition (CH), Massachusetts General Hospital, Children’s Hospital, and Harvard Medical School, Boston.
Background: Fat redistribution and metabolic abnormalities are seen increasingly in HIV-positive patients. However, the degree to which abnormalities in fat distribution predict glucose and insulin concentrations in these patients remains unknown.
Objective: We determined how well measurements of fat distribution derived from anthropometry, dual-energy X-ray absorptiometry, and computed tomography predicted hyperinsulinemia in HIV-positive men.
Design: Body-composition data were analyzed in 41 HIV-positive men (21 with fat redistribution and 20 without) and 20 HIV-negative control subjects matched for age and body mass index (BMI). Multivariate modeling was performed to determine the effects of body composition on fasting insulin and insulin area under the curve (AUC) during standard glucose tolerance testing.
Results: WHR was superior to other body-composition measures in predicting fasting hyperinsulinemia and was a strong predictor of insulin AUC in HIV-positive men. Fasting insulin increased by 77.4 pmol/L for each 0.1-unit change in WHR (95% CI: 18.6, 136.1; P = 0.011), overall r2 = 0.415 in a model also including age, BMI, and protease inhibitor use. Measures of intraabdominal and subcutaneous fat did not predict fasting hyperinsulinemia but were independent predictors of insulin AUC in multivariate modeling. The ratio of visceral to subcutaneous abdominal fat predicted the largest degree of variance in insulin AUC.
Conclusions: Fat redistribution contributes to hyperinsulinemia in HIV-positive men, independent of BMI and protease inhibitor use. WHR is an integrated index of body-composition changes and strongly predicts both fasting hyperinsulinemia and insulin AUC in HIV-positive men.
Key Words: HIV • insulin • lipodystrophy • visceral fat • waist-to-hip ratio • WHR • body composition • men
This article has been cited by other articles:
|
|
 |
|
  R. Scherzer, W. Shen, P. Bacchetti, D. Kotler, C. E Lewis, M. G Shlipak, S. B Heymsfield, and Carl Grunfeld for the Study of Fat Redistribution Simple anthropometric measures correlate with metabolic risk indicators as strongly as magnetic resonance imaging-measured adipose tissue depots in both HIV-infected and control subjects Am. J. Clinical Nutrition, June 1, 2008; 87(6): 1809 - 1817. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Torriani, B. J. Thomas, R. B. Barlow, J. Librizzi, S. Dolan, and S. Grinspoon Increased intramyocellular lipid accumulation in HIV-infected women with fat redistribution J Appl Physiol, February 1, 2006; 100(2): 609 - 614. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Hadigan, D. Kamin, J. Liebau, S. Mazza, S. Barrow, M. Torriani, R. Rubin, S. Weise, A. Fischman, and S. Grinspoon Depot-specific regulation of glucose uptake and insulin sensitivity in HIV-lipodystrophy Am J Physiol Endocrinol Metab, February 1, 2006; 290(2): E289 - E298. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Koutkia, B. Canavan, J. Breu, M. Torriani, J. Kissko, and S. Grinspoon Growth Hormone-Releasing Hormone in HIV-Infected Men With Lipodystrophy: A Randomized Controlled Trial JAMA, July 14, 2004; 292(2): 210 - 218. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Hadigan, S. Yawetz, A. Thomas, F. Havers, P. E. Sax, and S. Grinspoon Metabolic Effects of Rosiglitazone in HIV Lipodystrophy: A Randomized, Controlled Trial Ann Intern Med, May 18, 2004; 140(10): 786 - 794. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. D. Driscoll, G. E. Meininger, K. Ljungquist, C. Hadigan, M. Torriani, A. Klibanski, W. R. Frontera, and S. Grinspoon Differential Effects of Metformin and Exercise on Muscle Adiposity and Metabolic Indices in Human Immunodeficiency Virus-Infected Patients J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2171 - 2178. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M Hendricks, K. R Dong, A. M Tang, B. Ding, D. Spiegelman, M. N Woods, and C. A Wanke High-fiber diet in HIV-positive men is associated with lower risk of developing fat deposition Am. J. Clinical Nutrition, October 1, 2003; 78(4): 790 - 795. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Torriani, C. Hadigan, M. E. Jensen, and S. Grinspoon Psoas muscle attenuation measurement with computed tomography indicates intramuscular fat accumulation in patients with the HIV-lipodystrophy syndrome J Appl Physiol, September 1, 2003; 95(3): 1005 - 1010. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Hadigan, J. Rabe, G. Meininger, N. Aliabadi, J. Breu, and S. Grinspoon Inhibition of lipolysis improves insulin sensitivity in protease inhibitor-treated HIV-infected men with fat redistribution Am. J. Clinical Nutrition, February 1, 2003; 77(2): 490 - 494. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
